Glutathione peroxidase mimic ebselen improves glucose-stimulated insulin secretion in murine islets

Antioxidants and Redox Signaling

Volumn 20, Issue 2, 2014, Pages 191-203

  Wang, Xinhui ^a,b   Yun, Jun Won ^a   Lei, Xin Gen ^a  

^a Department of Obstetrics Gynecology   (United States)

^b SOUTH CHINA UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; EBSELEN; GLUCOSE; GLUCOSE TRANSPORTER 2; GLUTATHIONE PEROXIDASE 1; GLUTATHIONE REDUCTASE; HYDROGEN PEROXIDE; LACTATE DEHYDROGENASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; SUPEROXIDE; SUPEROXIDE DISMUTASE; UNCOUPLING PROTEIN 2;

ANTIOXIDANT ACTIVITY; ARTICLE; BIOINFORMATICS; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; GENOTYPE; GLUCOSE HOMEOSTASIS; HUMAN; INSULIN RELEASE; KNOCKOUT GENE; MEDIATOR RELEASE; MOLECULAR MIMICRY; NONHUMAN; PANCREAS ISLET; PEER REVIEW; PRIORITY JOURNAL; PROMOTER REGION; RNA INTERFERENCE; TRANSCRIPTION REGULATION;

ANIMALS; AZOLES; GLUCOKINASE; GLUCOSE; GLUCOSE TOLERANCE TEST; GLUCOSE TRANSPORTER TYPE 2; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HOMEODOMAIN PROTEINS; HYDRO-LYASES; INSULIN; ION CHANNELS; ISLETS OF LANGERHANS; MALE; MICE; MICE, KNOCKOUT; MITOCHONDRIAL PROTEINS; MOLECULAR MIMICRY; ORGANOSELENIUM COMPOUNDS; REACTIVE OXYGEN SPECIES; SELENIUM; SIGNAL TRANSDUCTION; SUPEROXIDE DISMUTASE; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

EID: 84891760300     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2013.5361     Document Type: Article

References (75)

1. Amacher DE. A toxicologists guide to biomarkers of hepatic response. Hum Exp Toxicol 21: 253-262, 2002.
2. Ashcroft FM and Rorsman P. Diabetes mellitus and the beta cell: the last ten years. Cell 148: 1160-1171, 2012.
3. Austin CP, Brady LS, Insel TR, and Collins FS. NIH molecular libraries initiative. Science 306: 1138-1139, 2004.
4. Barrett CW, Ning W, Chen X, Smith JJ, Washington MK, Hill KE, Coburn LA, Peek RM, Chaturvedi R, Wilson KT, Burk RF, and Williams CS. Tumor suppressor function of the plasma glutathione peroxidase gpx3 in colitis-Associated carcinoma. Cancer Res 73: 1245-1255, 2013.
5. Becker DJ, Reul B, Ozcelikay AT, Buchet JP, Henquin JC, and Brichard SM. Oral selenate improves glucose homeostasis and partly reverses abnormal expression of liver glycolytic and gluconeogenic enzymes in diabetic rats. Diabetologia 39: 3-11, 1996.
6. Bhat A, Koul A, Rai E, Sharma S, Dhar MK, and Bamezai RN. PGC-1alpha Thr394Thr and Gly482Ser variants are significantly associated with T2DM in two North Indian populations: a replicate case-control study. Hum Genet 121: 609-614, 2007.
7. Bisbal C, Lambert K, and Avignon A. Antioxidants and glucose metabolism disorders. Curr Opin Clin Nutr Metab Care 13: 439-446, 2010.
8. Bordonaro M. Role of Wnt signaling in the development of type 2 diabetes. Vitam Horm 80: 563-581, 2009.
9. Bowers GN, Jr. And McComb RB. A continuous spectrophotometric method for measuring the activity of serum alkaline phosphatase. Clin Chem 12: 70-89, 1966.
10. Brigelius-Flohe R. Glutathione peroxidases and redox-regulated transcription factors. Biol Chem 387: 1329-1335, 2006.
11. Brigelius-Flohe R and Flohe L. Basic principles and emerging concepts in the redox control of transcription factors. Antioxid Redox Signal 15: 2335-2381, 2011.
12. Cabou C and Burcelin R. GLP-1, the gut-brain, and brainperiphery axes. Rev Diabet Stud 8: 418-431, 2011.
13. Campbell SC, Aldibbiat A, Marriott CE, Landy C, Ali T, Ferris WF, Butler CS, Shaw JA, and Macfarlane WM. Selenium stimulates pancreatic beta-cell gene expression and enhances islet function. FEBS Lett 582: 2333-2337, 2008.
14. Costa MD, Gai BM, Acker CI, Souza AC, Brandao R, and Nogueira CW. Ebselen reduces hyperglycemia temporarilyinduced by diazinon: A compound with insulin-mimetic properties. Chem Biol Interact 197: 80-86, 2012.
15. Day BJ. Catalase and glutathione peroxidase mimics. Biochem Pharmacol 77: 285-296, 2009.
16. de-Mello MA, Flodstrom M, and Eizirik DL. Ebselen and cytokine-induced nitric oxide synthase expression in insulinproducing cells. Biochem Pharmacol 52: 1703-1709, 1996.
17. Ezaki O. The insulin-like effects of selenate in rat adipocytes. J Biol Chem 265: 1124-1128, 1990.
18. Feroci G and Fini A. Study of the antioxidant effect of several selenium and sulphur compounds. J Trace Elem Med Biol 12: 96-100, 1998.
19. Forman HJ. Reactive oxygen species and alpha,beta-unsaturated aldehydes as second messengers in signal transduction. Ann N Y Acad Sci 1203: 35-44, 2010.
20. Gandy SE, Buse MG, Sorenson JR, and Crouch RK. Attenuation of streptozotocin diabetes with superoxide dismutase-like copper(II)(3,5- diisopropylsalicylate)2 in the rat. Diabetologia 24: 437-440, 1983.
21. Gotoh M, Maki T, Kiyoizumi T, Satomi S, and Monaco AP. An improved method for isolation of mouse pancreatic islets. Transplantation 40: 437-438, 1985.
22. Gremlich S, Nolan C, Roduit R, Burcelin R, Peyot ML, Delghingaro-Augusto V, Desvergne B, Michalik L, Prentki M, and Wahli W. Pancreatic islet adaptation to fasting is dependent on peroxisome proliferator-Activated receptor alpha transcriptional up-regulation of fatty acid oxidation. Endocrinology 146: 375-382, 2005.
23. Gromada J, Holst JJ, and Rorsman P. Cellular regulation of islet hormone secretion by the incretin hormone glucagonlike peptide 1. Pflugers Arch 435: 583-594, 1998.
24. Heit JJ, Apelqvist AA, Gu X, Winslow MM, Neilson JR, Crabtree GR, and Kim SK. Calcineurin/NFAT signalling regulates pancreatic beta-cell growth and function. Nature 443: 345-349, 2006.
25. Helleboid-Chapman A, Helleboid S, Jakel H, Timmerman C, Sergheraert C, Pattou F, Fruchart-Najib J, and Fruchart JC. Glucose regulates LXRalpha subcellular localization and function in rat pancreatic beta-cells. Cell Res 16: 661-670, 2006.
26. Henquin JC. Pathways in beta-cell stimulus-secretion coupling as targets for therapeutic insulin secretagogues. Diabetes 53 Suppl 3: S48-S58, 2004.
27. Hoefig CS, Renko K, Kohrle J, Birringer M, and Schomburg L. Comparison of different selenocompounds with respect to nutritional value vs. Toxicity using liver cells in culture. J Nutr Biochem 22: 945-955, 2011.
28. Ianus A, Holz GG, Theise ND, and Hussain MA. In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion. J Clin Invest 111: 843-850, 2003.
29. Iwakami S, Misu H, Takeda T, Sugimori M, Matsugo S, Kaneko S, and Takamura T. Concentration-dependent dual effects of hydrogen peroxide on insulin signal transduction in H4IIEC hepatocytes. PLoS One 6: e27401, 2011.
30. Jensen MV, Joseph JW, Ronnebaum SM, Burgess SC, Sherry AD, and Newgard CB. Metabolic cycling in control of glucose-stimulated insulin secretion. Am J Physiol Endocrinol Metab 295: E1287-E1297, 2008.
31. Kao TC, Wu CH, and Yen GC. Glycyrrhizic acid and 18betaglycyrrhetinic acid recover glucocorticoid resistance via PI3K-induced AP1, CRE and NFAT activation. Phytomedicine 20: 295-302, 2013.
32. Ke Q, Li J, Ding J, Ding M, Wang L, Liu B, Costa M, and Huang C. Essential role of ROS-mediated NFAT activation in TNF-Alpha induction by crystalline silica exposure. Am J Physiol Lung Cell Mol Physiol 291: L257-L264, 2006.
33. KippA, BanningA, van Schothorst EM, Meplan C, Schomburg L, Evelo C, Coort S, Gaj S, Keijer J, Hesketh J, and Brigelius-Flohe R. Four selenoproteins, protein biosynthesis, and Wnt signalling are particularly sensitive to limited selenium intake in mouse colon. Mol Nutr Food Res 53: 1561-1572, 2009.
34. Kohen R and Nyska A. Oxidation of biological systems: oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification. Toxicol Pathol 30: 620-650, 2002.
35. Krauss S, Zhang CY, Scorrano L, Dalgaard LT, St-Pierre J, Grey ST, and Lowell BB. Superoxide-mediated activation of uncoupling protein 2 causes pancreatic beta cell dysfunction. J Clin Invest 112: 1831-1842, 2003.
36. Kryukov GV, Castellano S, Novoselov SV, Lobanov AV, Zehtab O, Guigo R, and Gladyshev VN. Characterization of mammalian selenoproteomes. Science 300: 1439-1443, 2003.
37. Labunskyy VM, Lee BC, Handy DE, Loscalzo J, Hatfield DL, and Gladyshev VN. Both maximal expression of selenoproteins and selenoprotein deficiency can promote development of type 2 diabetes-like phenotype in mice. Antioxid Redox Signal 14: 2327-2336, 2011.
38. Lei XG, Zhu JH, McClung JP, Aregullin M, and Roneker CA. Mice deficient in Cu,Zn-superoxide dismutase are resistant to acetaminophen toxicity. Biochem J 399: 455-461, 2006.
39. Lenzen S,Drinkgern J, and TiedgeM. Lowantioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues. Free Radic Biol Med 20: 463-466, 1996.
40. Ling C, Del Guerra S, Lupi R, Ronn T, Granhall C, Luthman H, Masiello P, Marchetti P, Groop L, and Del Prato S. Epigenetic regulation of PPARGC1A in human type 2 diabetic islets and effect on insulin secretion. Diabetologia 51: 615-622, 2008.
41. Lubos E, Loscalzo J, and Handy DE. Glutathione peroxidase-1 in health and disease: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal 15: 1957-1997, 2011.
42. Lugokenski TH, Muller LG, Taube PS, Rocha JB, and Pereira ME. Inhibitory effect of ebselen on lactate dehydrogenase activity from mammals: a comparative study with diphenyl diselenide and diphenyl ditelluride. Drug Chem Toxicol 34: 66-76, 2011.
43. Maiorino M, Roveri A, Coassin M, and Ursini F. Kinetic mechanism and substrate specificity of glutathione peroxidase activity of ebselen (PZ51). Biochem Pharmacol 37: 2267-2271, 1988.
44. Matschinsky FM. Assessing the potential of glucokinase activators in diabetes therapy. Nat Rev Drug Discov 8: 399-416, 2009.
45. Mazzarelli JM, Brestelli J, Gorski RK, Liu J, Manduchi E, Pinney DF, Schug J, White P, Kaestner KH, and Stoeckert CJ, Jr. EPConDB: a web resource for gene expression related to pancreatic development, beta-cell function and diabetes. Nucleic Acids Res 35: D751-D755, 2007.
46. McClung JP, Roneker CA, Mu W, Lisk DJ, Langlais P, Liu F, and Lei XG. Development of insulin resistance and obesity in mice overexpressing cellular glutathione peroxidase. Proc Natl Acad Sci U S A 101: 8852-8857, 2004.
47. Muller A, Cadenas E, Graf P, and Sies H. A novel biologically active seleno-organic compound-I. Glutathione peroxidase-like activity in vitro and antioxidant capacity of PZ 51 (Ebselen). Biochem Pharmacol 33: 3235-3239, 1984.
48. Pepper MP, Vatamaniuk MZ, Yan X, Roneker CA, and Lei XG. Impacts of dietary selenium deficiency on metabolic phenotypes of diet-restricted GPX1-overexpressing mice. Antioxid Redox Signal 14: 383-390, 2011.
49. Pi J, Bai Y, Zhang Q, Wong V, Floering LM, Daniel K, Reece JM, Deeney JT, Andersen ME, Corkey BE, and Collins S. Reactive oxygen species as a signal in glucose-stimulated insulin secretion. Diabetes 56: 1783-1791, 2007.
50. Pi J, Zhang Q, Fu J, Woods CG, Hou Y, Corkey BE, Collins S, and Andersen ME. ROS signaling, oxidative stress and Nrf2 in pancreatic beta-cell function. Toxicol Appl Pharmacol 244: 77-83, 2009.
51. Piwkowska A, Rogacka D, Angielski S, and Jankowski M. Hydrogen peroxide induces activation of insulin signaling pathway via AMP-dependent kinase in podocytes. Biochem Biophys Res Commun 428: 167-172, 2012.
52. Ponzani P. Long-term effectiveness and safety of liraglutide in clinical practice. Minerva Endocrinol 38: 103-112, 2013.
53. Puigserver P and Spiegelman BM. Peroxisome proliferatoractivated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator. Endocr Rev 24: 78-90, 2003.
54. Ramprasath T, Murugan PS, Kalaiarasan E, Gomathi P, Rathinavel A, and Selvam GS. Genetic association of glutathione peroxidase-1 (GPx-1) and NAD(P)H:quinone oxidoreductase 1(NQO1) variants and their association of CAD in patients with type-2 diabetes. Mol Cell Biochem 361: 143-150, 2012.
55. Robertson RP. Antioxidant drugs for treating beta-cell oxidative stress in type 2 diabetes: glucose-centric versus insulin-centric therapy. Discov Med 9: 132-137, 2010.
56. Schinner S, Ulgen F, Papewalis C, Schott M, Woelk A, Vidal-Puig A, and Scherbaum WA. Regulation of insulin secretion, glucokinase gene transcription and beta cell proliferation by adipocyte-derived Wnt signalling molecules. Diabetologia 51: 147-154, 2008.
57. Sies H. Ebselen, a selenoorganic compound as glutathione peroxidase mimic. Free Radic Biol Med 14: 313-323, 1993.
58. Singh N, Halliday AC, Thomas JM, Kuznetsova OV, Baldwin R, Woon EC, Aley PK, Antoniadou I, Sharp T, Vasudevan SR, and Churchill GC. A safe lithium mimetic for bipolar disorder. Nat Commun 4: 1332, 2013.
59. Soyal S, Krempler F, Oberkofler H, and Patsch W. PGC-1alpha: a potent transcriptional cofactor involved in the pathogenesis of type 2 diabetes. Diabetologia 49: 1477-1488, 2006.
60. St-Pierre J, Drori S, Uldry M, Silvaggi JM, Rhee J, Jager S, Handschin C, Zheng K, Lin J, Yang W, Simon DK, Bachoo R, and Spiegelman BM. Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell 127: 397-408, 2006.
61. Steinbrenner H, Hotze AL, Speckmann B, Pinto A, Sies H, Schott M, Ehlers M, Scherbaum WA, and Schinner S. Localization and regulation of pancreatic selenoprotein P. J Mol Endocrinol 50: 31-42, 2013.
62. Tkachev VO, Menshchikova EB, and Zenkov NK. Mechanism of the Nrf2/Keap1/ARE signaling system. Biochemistry (Mosc) 76: 407-422, 2011.
63. Tong Y, Lin Y, Zhang Y, Yang J, Liu H, and Zhang B. Association between TCF7L2 gene polymorphisms and susceptibility to type 2 diabetes mellitus: a large Human Genome Epidemiology (HuGE) review and meta-Analysis. BMC Med Genet 10: 15, 2009.
64. Tordjman K, Standley KN, Bernal-Mizrachi C, Leone TC, Coleman T, Kelly DP, and Semenkovich CF. PPARalpha suppresses insulin secretion and induces UCP2 in insulinoma cells. J Lipid Res 43: 936-943, 2002.
65. van Raalte DH, van Leeuwen N, Simonis-Bik AM, Nijpels G, van Haeften TW, Schafer SA, Boomsma DI, Kramer MH, Heine RJ, Maassen JA, Staiger H, Machicao F, Haring HU, Slagboom PE, Willemsen G, de Geus EJ, Dekker JM, Fritsche A, Eekhoff EM, Diamant M, and t Hart LM. Glucocorticoid receptor gene polymorphisms are associated with reduced first-phase glucose-stimulated insulin secretion and disposition index in women, but not in men. Diabet Med 29: e211-e216, 2012.
66. Wang L, Jiang Z, and Lei XG. Knockout of SOD1 alters murine hepatic glycolysis, gluconeogenesis, and lipogenesis. Free Radic Biol Med 53: 1689-1696, 2012.
67. Wang X, Gillen EA, van der Meulen MC, and Lei XG. Knockouts of Se-glutathione peroxidase-1 and Cu,Zn superoxide dismutase exert different impacts on femoral mechanical performance of growing mice. Mol Nutr Food Res 52: 1334-1339, 2008.
68. Wang X, Vatamaniuk MZ, Roneker CA, Pepper MP, Hu LG, Simmons RA, and Lei XG. Knockouts of SOD1 and GPX1 exert different impacts on murine islet function and pancreatic integrity. Antioxid Redox Signal 14: 391-401, 2011.
69. Wang XD, Vatamaniuk MZ, Wang SK, Roneker CA, Simmons RA, and Lei XG. Molecular mechanisms for hyperinsulinaemia induced by overproduction of seleniumdependent glutathione peroxidase-1 in mice. Diabetologia 51: 1515-1524, 2008.
70. Wen JW, Hwang JT, and Kelly GM. Reactive oxygen species and Wnt signalling crosstalk patterns mouse extraembryonic endoderm. Cell Signal 24: 2337-2348, 2012.
71. Xiao H and Parkin KL. Induction of phase II enzyme activity by various selenium compounds. Nutr Cancer 55: 210-223, 2006.
72. Yamaguchi T, Sano K, Takakura K, Saito I, Shinohara Y, Asano T, and Yasuhara H. Ebselen in acute ischemic stroke: a placebo-controlled, double-blind clinical trial. Ebselen Study Group. Stroke 29: 12-17, 1998.
73. Yang Y, Mo X, Chen S, Lu X, and Gu D. Association of peroxisome proliferator-Activated receptor gamma coactivator 1 alpha (PPARGC1A) gene polymorphisms and type 2 diabetes mellitus: a meta-Analysis. Diabetes Metab Res Rev 27: 177-184, 2011.
74. Zhang CY, Baffy G, Perret P, Krauss S, Peroni O, Grujic D, Hagen T, Vidal-Puig AJ, Boss O, Kim YB, Zheng XX, Wheeler MB, Shulman GI, Chan CB, and Lowell BB. Uncoupling protein-2 negatively regulates insulin secretion and is a major link between obesity, beta cell dysfunction, and type 2 diabetes. Cell 105: 745-755, 2001.
75. Zhu JH and Lei XG. Double null of selenium-glutathione peroxidase-1 and copper, zinc-superoxide dismutase enhances resistance of mouse primary hepatocytes to acetaminophen toxicity. Exp Biol Med (Maywood) 231: 545-552, 2006.